This website uses cookies to enhance the user experience.
21st logo
||
B

BIBRA AS925 560 650

Limited company
c/o Ole Bratt Birkeland Skjoldvegen 63B 5221 NESTTUN, Norge

BIBRA AS

Operating
Å investere i aksjer, obligasjoner, selskapsandeler, eiendom og andre investeringsobjekter, samt hva hermed står i forbindelse.

Organization

Chairman of the board
Years since formation
6 years
since Aug 31, 2020
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100
2 share classes
Total number of shareholders
3
persons

Financials

Total operating income 2025
180,000
NOK
Annual total result 2025
1,053,418
NOK
Total equity 2025
52,431,992
NOK
Last update: Jun 18, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Alternate Member-

Others

NameRoleShares
B
BJØRGVIN REVISJON AS
Auditor-
B
BRYGGEN REVISJON AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
49 %
directly
-
49 %
directly
-
2 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Class B shares
49
49 %
Class B shares
49
49 %
A-shares
2
2 %

Shares owned by the BIBRA AS

NameShare classTotal number of sharesShare
V
VINO PIEMONTE AS
Ordinary shares
60,000
1.39 %
C
CLEAN FISH GROUP AS
Closed
Ordinary shares
160,000
0.41 %
B
BERGEN CARBON SOLUTIONS AS
Ordinary shares
25,083
0.06 %
A
AXACTOR ASA
Ordinary shares
180,000
0.06 %
N
NAVAMEDIC ASA
Ordinary shares
6,003
0.03 %
E
ELOPAK ASA
Ordinary shares
3,000
< 0.01 %
X
XPLORA TECHNOLOGIES AS
Ordinary shares
4,000
< 0.01 %
A
ATEA ASA
Ordinary shares
700
< 0.01 %
A
AUSTEVOLL SEAFOOD ASA
Ordinary shares
1,000
< 0.01 %
A
AKVA GROUP ASA
Ordinary shares
4,000
< 0.01 %
M
MEDISTIM ASA
Ordinary shares
2,012
< 0.01 %
N
NORDIC SEMICONDUCTOR ASA
Ordinary shares
2,000
< 0.01 %
B
BOUVET ASA
Ordinary shares
3,000
< 0.01 %
L
LERØY SEAFOOD GROUP ASA
Ordinary shares
1,000
< 0.01 %
P
PROTECTOR FORSIKRING ASA
Ordinary shares
1,800
< 0.01 %
N
NYKODE THERAPEUTICS ASA
Ordinary shares
2,000
< 0.01 %
Z
ZELLUNA ASA
Ordinary shares
400
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
180,000
180,000
175,000
155,000
165,000
Annual Total Result
1,053,418
4,597,289
3,433,981
-4,317,737
3,443,032
Total assets
55,061,523
57,188,640
55,188,287
54,353,687
58,732,858
Total liabilities
2,629,531
3,210,066
7,003
6,384
67,818
Total equity
52,431,992
53,978,573
55,181,284
54,347,303
58,665,040

P&L

Year20252024202320222021
Total operating income
180,000
180,000
175,000
155,000
165,000
Total operating costs
885,744
871,829
863,901
919,601
1,013,704
Operating result
-705,744
-691,829
-688,901
-764,601
-848,704
Financial income/costs
1,783,627
5,289,118
4,122,882
-3,553,135
4,291,736
Profit before tax
1,077,883
4,597,289
3,433,981
-4,317,737
3,443,032
Total tax & extraordinary income/cost
24,465
0
0
0
0
Annual Total Result
1,053,418
4,597,289
3,433,981
-4,317,737
3,443,032

Balance overview

Year20252024202320222021
Total fixed assets
9,448,757
10,134,057
10,138,457
10,142,857
8,170,950
Total current assets
45,612,766
47,054,583
45,049,830
44,210,830
50,561,908
Total assets
55,061,523
57,188,640
55,188,287
54,353,687
58,732,858
Short term debt
2,629,531
3,210,066
7,003
6,384
67,818
Long term debt
0
0
0
0
0
Total liabilities
2,629,531
3,210,066
7,003
6,384
67,818
Contributed capital
100,000
100,000
100,000
100,000
100,000
Retained earnings
52,331,992
53,878,573
55,081,284
54,247,303
58,565,040
Total equity
52,431,992
53,978,573
55,181,284
54,347,303
58,665,040
Total equity and liabilities
55,061,523
57,188,640
55,188,287
54,353,687
58,732,858

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification